ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $60,000 | -18.9% | 42,408 | 0.0% | 0.08% | -19.6% |
Q3 2016 | $74,000 | +1.4% | 42,408 | 0.0% | 0.10% | -7.3% |
Q2 2016 | $73,000 | -13.1% | 42,408 | 0.0% | 0.11% | -9.1% |
Q1 2016 | $84,000 | -22.9% | 42,408 | -25.2% | 0.12% | -12.9% |
Q4 2015 | $109,000 | -0.9% | 56,665 | 0.0% | 0.14% | -1.4% |
Q3 2015 | $110,000 | -58.3% | 56,665 | 0.0% | 0.14% | -53.0% |
Q2 2015 | $264,000 | +6.5% | 56,665 | -0.2% | 0.30% | +11.5% |
Q1 2015 | $248,000 | +26.5% | 56,775 | 0.0% | 0.27% | +31.2% |
Q4 2014 | $196,000 | -17.6% | 56,775 | 0.0% | 0.20% | -19.0% |
Q3 2014 | $238,000 | -28.7% | 56,775 | 0.0% | 0.25% | -15.1% |
Q2 2014 | $334,000 | -7.0% | 56,775 | 0.0% | 0.30% | -5.1% |
Q1 2014 | $359,000 | +7.5% | 56,775 | 0.0% | 0.31% | 0.0% |
Q4 2013 | $334,000 | +11.7% | 56,775 | 0.0% | 0.31% | +16.7% |
Q3 2013 | $299,000 | -37.4% | 56,775 | -8.1% | 0.27% | -44.4% |
Q2 2013 | $478,000 | – | 61,775 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
GAM Holding AG | 523,164 | $997,000 | 0.02% |
STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |